| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |